The 20 Best AIDS Dementia Complex Doctors Near Me in Towson, MD

Chandralekha Banerjee is an Infectious Disease provider in Baltimore, Maryland. Dr. Banerjee is rated as a Distinguished provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are Myelitis, HIV/AIDS, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Christopher Hoffmann's primary appointment is in the Department of Medicine, Division of Infectious Diseases. His areas of clinical expertise include HIV/AIDS and infectious diseases. Dr. Hoffmann earned his M.D. and M.P.H. from Oregon Health and Sciences University. He completed his residency at Johns Hopkins and performed a fellowship in infectious diseases at Johns Hopkins. His research interests include care delivery and care utilization, in low- and middle-income settings (mostly Africa), and clinical management of HIV and TB. Dr. Hoffmann is a member of several professional organizations, including the American College of Physicians and the Infectious Diseases Society of America. Dr. Hoffmann is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine. Dr. Melia is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Sara Keller graduated from the Duke University School of Medicine in 2007. She completed her Master of Public Health in epidemiology in 2006 at the University of North Carolina at Chapel Hill. She then completed a residency in Internal Medicine in the Osler Medical Residency Training Program at the Johns Hopkins Hospital in 2010, a fellowship in Infectious Diseases at the University of Pennsylvania in 2012, and a fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety in 2013. She also completed a Master of Science in Health Policy at the University of Pennsylvania in 2013. She is an Assistant Professor in Infectious Diseases where she primarily sees patients at Johns Hopkins Green Spring Station and also attends on the inpatient infectious disease consult service at the Johns Hopkins Hospital. She serves as the Medical Director of the Johns Hopkins Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service. Dr. Keller is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are Asymptomatic Bacteriuria, Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis. Dr. Lippincott is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.

Kjell Wiberg is an Infectious Disease provider in Baltimore, Maryland. Dr. Wiberg is rated as a Distinguished provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Christie Basseth is a clinical associate at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Basseth earned her M.D. from the University of Medicine and Dentistry of New Jersey. She completed her residency at Montefiore Medical Center and performed a fellowship at New York-Presbyterian Hospital/Columbia. Dr. Basseth is rated as a Distinguished provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, and AIDS Dementia Complex.

Richard Berg is an Internal Medicine provider in Baltimore, Maryland. Dr. Berg is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are St. Anthony's Fire, Erysipelas, Myelitis, Gastrostomy, and Carotid Artery Surgery. Dr. Berg is currently accepting new patients.

Elie Khalil is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Khalil is rated as an Experienced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Infectious Arthritis, Osteomyelitis, Osteomyelitis in Children, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. Dr. Karakousis is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Emily Kendall is an Associate Professor of Medicine in the Infectious Diseases division at the Johns Hopkins University School of Medicine. Her research focuses on tuberculosis epidemiology and infectious disease dynamics. Dr. Kendall received her B.A. from Harvard University and her M.D. from the Vanderbilt University School of Medicine. She completed her residency at Massachusetts General Hospital and a fellowship in infectious diseases at Johns Hopkins. Dr. Kendall is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Stephen Berry is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV medicine and general infectious diseases. He serves as the Vice Chair for Quality, Safety and Service in the Department of Medicine. Dr. Berry graduated summa cum laude from Emory University and joined the Peace Corps to work as a science teacher in Malawi. He then completed medical school, an internal medicine residency and a chief resident year at the University of Pennsylvania School of Medicine. He performed a fellowship in infectious diseases at Johns Hopkins as well as a Ph.D. from the graduate training program in clinical investigation. Dr. Berry joined the Johns Hopkins faculty in 2010. Dr. Berry’s research focuses on health services utilization and quality and secondary HIV prevention among persons living with HIV. He also focuses on the role of quality metrics in the US healthcare system's transition to value based care. Dr. Berry is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, and HIV/AIDS.

Dr. Joyce Leitch Jones is a faculty member at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious diseases. Dr. Jones earned her M.D. at the University of Maryland School of Medicine. She completed her residency at Columbia University Medical Center and performed a fellowship in epidemiology at Weill Cornell Medical College. Dr. Jones is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are Myelitis, HIV/AIDS, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Gregory M. Lucas is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS and infectious disease. Dr. Lucas received his undergraduate degree from the University of Notre Dame. He earned his M.D. from Duke University School of Medicine and his Ph.D. from Johns Hopkins. He completed his residency and performed a fellowship in infectious diseases at Johns Hopkins. He serves on the faculties of the Center for AIDS Research, where he is co-director of the Substance Use Scientific Working Group; the Center for Substance Abuse Treatment and Research; the Center for Adolescent Health; and the Heart and Vascular Institute. Dr. Lucas is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, Hepatitis C, Myelitis, and AIDS Dysmorphic Syndrome.

Amita Gupta is an Infectious Disease provider in Baltimore, Maryland. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of AIDS Dementia Complex. Her top areas of expertise are Myelitis, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, and HIV/AIDS.